Insmed raises peak sales guidance to $14 billion
Insmed (INSM) raised peak sales guidance to $14 billion, citing strong BRINSUPRI and TPIP performance and expanding indications. It expects profitability next year.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.